You have nothing in your cart

  • Home
  • |
  • Company
  • |
  • News
  • |
  • Brexit for the Pharmaceutical Industry. The clock is ticking.

Brexit for the Pharmaceutical Industry. The clock is ticking.

After Brexit, without mutual recognition between regulatory bodies, Pharmaceutical companies with a UK Marketing Authorisation, will not be allowed to release their products to the UK market without batch release testing performed by an MHRA GMP audited laboratory.

Now is the time to plan and select your UK batch release testing partner before Friday 29th March 2019. To access the UK market, you will need to:

  • Have audited the preferred partner for batch release testing.
  • Have the selected GMP inspected laboratory on your license.
  • Have completed method transfers to the selected partner laboratory.

To remain in the UK market place Pharmaceutical companies need to act now!

Source Bioscience’s analytical division is a leading independent, MHRA approved (cGMP) contract research organisation that specialises in the provision of batch release testing into the UK & European market place. Sited in Scotland near to Edinburgh International Airport, giving easy access to the facility, we welcome enquiries from companies actively seeking product release in the UK.

As part of our provision of the service we conform to current Good Manufacturing Practice (cGMP).

Contact Source BioScience to discuss your requirements at:
Tel : +44 (0) 115 973 9012
Email :

©2017 Source BioScience. All rights reserved